Xing-Sheng Hu (Xingsheng Hu)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Circulating Tumor

Smoking Cessation

Tyrosine Kinase

Radiation Therapy

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Feng, Yunxia Tao, Haizhu Chen, Yu Zhou, Le Tang, Chenwei Liu, Xing-Sheng Hu, Yuan-Kai Shi
Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis. Thoracic cancer (2023)
Mingzhao Wang, Jun Zhao, Tong Chen, Xing-Sheng Hu, Lin Wang, Yuan-Kai Shi, Yutao Liu
Efficacy and safety of osimertinib plus anlotinib in advanced non-small-cell lung cancer patients after drug resistance. Thoracic cancer (2023)
Yu Feng, Liling Huang, Haohua Zhu, Le Tang, Xing-Sheng Hu, Yuan-Kai Shi
The exploration of three different treatment models of osimertinib plus antiangiogenic agents in non-small cell lung cancer: A real-world study. Thoracic cancer 13 (18) (2022)
Teng Li, Shouzheng Wang, Jianming Ying, Yan Wang, Xing-Sheng Hu, Xuezhi Hao, Ziyi Xu, Puyuan Xing, Jun-Ling Li
Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations. Thoracic cancer 12 (21) (2021)
Hao-Hua Zhu, Yu-Tao Liu, Yu Feng, Li-Na Zhang, Tong-Mei Zhang, Gui-Lan Dong, Pu-Yuan Xing, Hong-Yu Wang, Yuan-Kai Shi, Xing-Sheng Hu
Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis. Thoracic cancer 12 (20) (2021)